Shanghai Henlius Biotech, Inc. (2696.HK) HKSE

60.10

-0.9(-1.48%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap12.1B
Enterprise Value14.97B
P/E Ratio35.73
PEG Ratio0.36
Price/Sales Ratio5.08
Price/Book Ratio8.64
Enterprise/Revenue5.56
Enterprise/EBITDA28.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.15

Management Effectiveness

Return On Assets0.07
Return On Equity0.26

Income Statement

Revenue5.72B
Revenue/Share10.67
Gross Profit4.18B
EBITDA1.15B
Net Income820.47M
Diluted EPS1.51

Balance Sheet

Total Cash972.5M
Total Cash/Share1.79
Total Debt3.67B
Total Debt/Equity1.08
Current Ratio0.68
Book Value Per Share6.27

Price History

52-Week Change151.46
52-Week High92
52-Week Low15.2
Moving Average 50 Days65.98
Moving Average 200 Days58.02

Statistics

Average Volume1.13M
Shares Outstanding543.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A